Related by context. All words. (Click for frequent words.) 65 Biomarker 64 biomarkers 62 Cancer Therapies 60 biomarker 60 Circulating Tumor Cells 59 Toxicogenomics 59 Metabolomics 59 Metabolic Disease 59 Novel Therapies 59 Therapeutic Targets 58 molecular biomarkers 58 Cancer Vaccines 58 Microarrays 58 Bladder Cancer 58 Pharmacogenomic 58 RNAi Therapeutics 58 Monoclonal Antibodies 58 Chemotherapeutic Agents 57 Cancer Biomarkers 57 Novel Approaches 57 Molecular Cancer 57 Insulin Resistance 57 Analytical Tool 57 Small Molecule 57 Genetic Markers 57 Nicotine Vaccine 57 Phenotypes 57 DNA Sequencing 57 Breast Cancer Metastasis 57 RNA Interference 57 Clinical Validation 57 Angiogenesis 57 Oxidative Stress 57 Oligonucleotides 57 Proteomics 57 Autoimmune Disease 57 Effective Treatments 57 Personalised Medicine 56 Genetic Variation 56 Malignancies 56 Neurodegenerative Disease 56 Clinical Outcome 56 Cancer Stem Cells 56 Cardiotoxicity 56 Small Molecules 56 Chemoprevention 56 Therapeutic Potential 56 Pathogenesis 56 Molecular Diagnostics 56 Anti Tumor 56 diagnostic biomarkers 56 Therapeutic Antibodies 56 Immunotherapeutic 56 Lipids 56 ASCO GU 56 Drug Metabolism 56 diagnostic biomarker 56 Meta Analysis 56 Cognitive Decline 56 Targeted Therapy 56 Kinase Inhibitors 55 Targeted Therapies 55 Proteomic 55 Molecular Therapy 55 Therapeutic Vaccines 55 Autoimmune Diseases 55 Therapeutic Antibody 55 Clinical Trial Results 55 Thyroid Hormone 55 Aggressive Prostate Cancer 55 Dendritic Cells 55 salivary diagnostics 55 Drug Discovery 55 Innate Immunity 55 Oncogene 55 Protein Expression 55 Preclinical Study 55 Molecular Mechanisms 55 biomarker discovery 55 Gene Expression Profiling 55 Novel Treatments 55 Cancer Treatments 55 Prognostic 55 Mimetics 55 Gene Mutation 55 metabolomics 55 Tumor Microenvironment 55 Flow Cytometry 55 Breast Tumors 55 MicroRNA 55 Biomarker Discovery 55 journal Cancer Epidemiology 55 Salivary 54 DNA Methylation 54 Genetic Testing 54 Lung Cancer Screening 54 Personalized Medicine 54 Systemic Delivery 54 Biocompatibility 54 Protein Therapeutics 54 Diagnostic Criteria 54 Neuroprotection 54 Protein Interactions 54 genomic proteomic 54 Non Invasive 54 epigenomics 54 Platelet Inhibition 54 Diagnosis Treatment 54 Hepatitis C Virus 54 Viral Infections 54 Gastric Cancer 54 Laryngeal Cancer 54 Arteriosclerosis Thrombosis 54 protein biomarker discovery 54 Novel Therapeutics 54 Inflammatory Arthritis 54 Chronic Inflammation 54 Biomarker Study 54 Renal Cancer 54 Breast Density 54 RNAi Therapeutic 54 Prognostic Value 54 Lung Cancer Patients 54 Brain Tumors 54 Osteoporosis Treatment 54 Genetic Predisposition 54 Neurodegenerative 54 Prolongs Survival 54 transcriptomics 54 Mass Spectrometry 54 Organ Rejection 54 Tumor Targeting 54 Benign Prostatic Hyperplasia 54 Immune Cell 54 Risk Stratification 54 Protein Linked 54 Novel Method 53 Next Generation Sequencing 53 Cardiovascular Disease 53 Motility 53 Genetic Marker 53 Molecular Basis 53 Biochips 53 Noninvasive Prenatal 53 Oral Fingolimod 53 Epitopes 53 Prostate Cancer Treatment 53 Kinases 53 journal Biomacromolecules 53 Anticancer Drugs 53 Inhibitors 53 Micro RNAs 53 Gene Variants 53 pharmacogenetic test 53 Inflammatory Disease 53 Translational 53 Researchers Identify 53 Synthetic Peptide 53 Urinary Incontinence 53 Vitro Diagnostic 53 Molecular Diagnostic 53 Signaling Pathway 53 Genes Linked 53 Quantitation 53 Diagnostic Tests 53 Spinal Fluid 53 Gene Silencing 53 Protein Interaction 53 Cardiovascular Outcomes 53 Randomized Controlled Trials 53 Pharmacogenetic 53 Unresectable 53 Breast Cancer Recurrence 53 Aptamer 53 Therapeutic Advances 53 Genes Involved 53 KRAS mutation 53 Oral Mucositis 53 Neoplasia 53 Epithelium 53 Hyperlipidemia 53 Cognitive Deficits 53 Gene Expression 53 Preclinical Data 53 Gene Therapy 53 tumor hypoxia 53 Signaling Pathways 53 Genetic Basis 53 Subtypes 53 Neural Stem Cells 53 Metabolic Endocrinology 53 Recombinant Protein 53 Gene Linked 53 Ischemic 53 Metastases 53 Cancer Therapeutics 53 Early Diagnosis 53 Genetic Variations 53 Inflammatory Markers 53 Nano Particles 53 Cancer Epidemiology Biomarkers 53 Myelodysplastic Syndromes 53 Biological Therapy 53 Brain Stimulation 53 Mesenchymal Stem Cells 53 Protein Biomarkers 53 Dyslipidemia 53 Carcinogenesis 53 Hepatocellular Carcinoma 53 Treating Chronic 53 Chronic Lymphocytic Leukemia 53 Scientists Identify 53 Metabolic Syndrome 53 Cognitive Problems 53 Absorption Distribution 53 Hedgehog Pathway 53 predictive toxicology 53 TNF Alpha 53 Mouse Model 53 Transcriptome 53 Pipeline Analysis 53 Solubility 53 Drug Shows Promise 53 Factor Receptor 53 Cognitive Function 52 Immunochemistry 52 Tumor Suppressor 52 Cytometry 52 Kidney Function 52 Antisense 52 pharmacogenetic tests 52 Solid Tumors 52 Progenitor Cells 52 Pharmacogenomics 52 Dose Response 52 Colon Polyps 52 OTCBB PWRM.OB 52 Protein Biomarker 52 Protein Kinase 52 Treatment Approaches 52 Hypercholesterolemia 52 Clinical Trial Data 52 Genes Identified 52 Phenotype 52 Theranostics 52 Tumor Angiogenesis 52 Hormone Therapy 52 Antifungals 52 journal Molecular 52 Emerging Therapies 52 Postdoctoral Position 52 predictive biomarkers 52 Nanobiotechnology 52 Biophysical 52 Antisense Drug 52 Diabetic Nephropathy 52 Cytokines 52 Science Translational Medicine 52 Drug Prevents 52 ADME Tox 52 Epidermal Growth Factor Receptor 52 Nanoparticles 52 Drug Pipeline 52 Hematopoietic 52 Physiology Seminar 52 Shows Promise Against 52 Lipid Metabolism 52 Embryonic Stem Cells 52 Genetic Mutation 52 Lung Cancer Drug 52 Immunoassays 52 metabolomic profiling 52 siRNA Delivery 52 Gas Chromatography 52 Reperfusion Injury 52 DNA microarrays 52 Biochip 52 protein biomarker 52 Gene Mutations 52 Biomarker Panel 52 Tumor Cells 52 Systematic Review 52 Tr DNA 52 molecular markers 52 validate biomarkers 52 Mantle Cell Lymphoma 52 Cellular Therapy 52 prognostic markers 52 Biopharmaceutical Industry 52 Brain Tumor Therapy 52 Genes Associated 52 Cancer Immunotherapy 52 Breast Cancer Cells 52 Autoimmunity 52 Antimicrobials 52 Oral Presentations 52 blood serum biomarkers 52 eTag assays 52 molecular profiling 52 Genetic Variant 52 Long Term Efficacy 52 Leukemias 52 #th Interscience Conference 52 Oligonucleotide 52 Initiates Clinical Trial 52 gene expression profiling 52 Anthracycline 52 Neurodegenerative diseases 52 Mouse Models 52 ASCO GI 52 Transdermal Delivery 52 Synaptic Plasticity 52 Inflammatory Bowel Diseases 52 Tumor Progression 52 EMBO Journal 52 Raman Spectroscopy 52 Present Preclinical Data 52 Antiangiogenic 52 Genetic Variants 52 metabolomic 52 Erectile Dysfunction Drug 52 Clinical Trials 52 Predisposition 52 Gene Variant 52 Predictive Toxicology 52 Cell Transplant 52 Rheumatoid Arthritis Drug 52 Blood Vessels 52 Nuclear Receptors 52 Neurodegenerative Diseases 52 Gene Variation 52 Porous Materials 52 proteomics genomics 52 Experimental Neurology 52 hERG 52 Amyloid 52 sirtuin therapeutics 51 Anthrax Toxin 51 Peripheral Blood 51 Molecular Markers 51 Liposomal 51 Therapeutic Effects 51 Intracellular 51 Postmenopausal Women 51 Kinase Inhibitor 51 Inflammatory Diseases 51 Growth Hormone Deficiency 51 Innate Immune 51 Invasive Breast Cancer 51 Cytogenetic 51 Clinical Proteomics 51 Small Intestine 51 Nanomaterial 51 CTRC AACR San Antonio 51 Outpatient Setting 51 Stem Cells 51 Novel Vaccine 51 Metabolites 51 KineMed 51 Metastatic Cancer 51 Molecular imaging 51 Glucose Metabolism 51 Immunotherapies 51 Vaccine Immunology 51 Hsp# Inhibitor 51 Immunotherapy 51 Immune Mediated 51 Mutagenesis 51 personalized medicine 51 PGx 51 companion diagnostics 51 Genetic Tests 51 Nucleic Acid 51 Knee Osteoarthritis 51 CYT# potent vascular disrupting 51 Conjugated 51 Treatment Options 51 Safinamide 51 Metastasis 51 Liver Cirrhosis 51 lipid metabolites 51 Imaging Biomarkers 51 toxicogenomics 51 Preclinical Development 51 Bone Metastases 51 Clinical Cancer 51 Skeletal Muscle 51 Ion Channels 51 Brain Scans 51 Smooth Muscle 51 Adult Stem Cells 51 Detect Cancer 51 Clinically Significant 51 Anticancer Activity 51 Carotid Stenting 51 Beneficial Effects 51 Commercialize Novel 51 Peptides 51 Differential Diagnosis 51 Multimodality 51 Recurrent Breast Cancer 51 Renal Cell Carcinoma 51 Statin Drugs 51 Treatment Regimen 51 Crystallographic 51 Anti Angiogenesis 51 Eye Diseases 51 Long Term Survival 51 Disease Models 51 Extracellular Matrix 51 Poster Presentations 51 Cognitive Disorders 51 HDAC Inhibitors 51 Cancer Cells 51 myelofibrosis polycythemia vera 51 Test Detects 51 Alimentary Pharmacology 51 Glucose Monitoring 51 Molecular Origins 51 journal Nature Reviews 51 Multicenter Randomized 51 Pooled Analysis 51 Late Breaker 51 Lung Cancer Survival 51 Angiogenic 51 Carbon Nanotubes 51 Islet Transplantation 51 Endometrial 51 Fabry Disease 51 Ovarian Cancers 51 AttoSense 51 Technological Advances 51 Breast Cancers 51 genetic biomarkers 51 Electrophysiology Mapping 51 Neuroendocrine 51 Novel Mechanism 51 Phosphatase 51 protein biomarkers 51 Epigenomics proprietary 51 Retrovirus 51 Prospective Multicenter 51 Thyroid Disease 51 Septin9 biomarker 51 Allosteric 51 Molecular Profiling 51 Tumor Suppressor Gene 51 High Throughput 51 proteomics 51 Tumor Growth 51 Iron Overload 51 Genetic Mutations 51 Endothelial 51 Bucindolol 51 Analytical Method 51 Antibody Therapeutics 51 Iron Deficiency 51 SurroMed 51 Protein Crystallography 51 Prostate Cancers 51 Hormone Receptor Positive 51 Hormone Refractory Prostate Cancer 51 Estrogen Receptor 51 Microbicide 51 Epigenetics 51 biomarker assays 51 Preclinical Studies 51 Maven Semantic 51 Novel Oral 51 Macromolecules 51 neuronal nicotinic receptors NNRs 51 FOLOTYN ® 51 Insulin Sensitivity 51 miRNA biomarkers 51 Renal Function 51 Treating Depression 51 rxRNA 51 Gender Differences 51 Protein Synthesis 51 Molecular 50 Nasdaq IDRA today 50 Medicinal Chemistry Letters 50 biomolecular interactions 50 Breast Tumor 50 Autoimmune Disorders 50 Human Gene Therapy 50 Prenatal Diagnosis 50 Trofex 50 Cell Transplantation 50 Imaging Technique 50 Genetic Screening 50 Immunologic 50 Breast Cancer Treatment 50 Cystatin C 50 Drug Candidate 50 Venous Thromboembolism 50 Novel Therapeutic 50 pharmacogenomic 50 Inflammation 50 Enlarged Prostate 50 Nicotine Addiction 50 Molecular Diagnostic Test 50 Sleep Disturbances 50 Therapeutic Agents 50 Neurochemistry 50 Lymph Nodes 50 Intervention Effectiveness 50 Coronary Artery Calcium 50 Cell Adhesion 50 Analgesia 50 BioMAP 50 Malignant Melanoma 50 Carcinoma 50 Diagnostic Tools 50 Clinical Efficacy 50 Beta Amyloid 50 Lipoprotein 50 Metastatic Melanoma 50 Companion Diagnostics 50 Protein Involved 50 proteomic 50 Antiviral Therapy 50 Brain Functions 50 KRAS variant 50 Prognostic Factors 50 Mechanistic 50 Tumor Markers 50 Tyrosine Kinase Inhibitor 50 antithrombotic agents 50 Phase 2a Trial 50 Randomized Study 50 Prostate Cancer Patients 50 Gene Expression Analysis 50 Help Predict 50 Breast Ovarian Cancer 50 Breast Tissue 50 microRNA biomarkers 50 Helps Diagnose 50 ASH Annual Meeting 50 Coronary Disease 50 Vascular Targeting Agents 50 Ovarian Cancer Patients 50 Lymphoid 50 biomarker identification 50 Diabetic Retinopathy 50 Genedata 50 Elixir Pharmaceuticals 50 serum biomarkers 50 kidney urologic 50 DNA Microarray 50 Neurotherapeutics 50 Immune Cells 50 Shows Efficacy 50 Malignant Mesothelioma 50 Nature Methods 50 Osteoporosis Drug 50 Anti Tumor Activity 50 IL# PE#QQR 50 Therapeutic Approaches 50 Thromboembolism 50 Improves Survival 50 Therapeutics TCT scientific 50 Fibrosis 50 Therapeutic Vaccine 50 Myocardial Ischemia 50 Investigational Drugs 50 Pulmonary Arterial Hypertension 50 Antisense Oligonucleotides 50 Neuropathic Pain 50 AACR San Antonio 50 DNA methylation markers 50 Osteopontin 50 Therapeutic Efficacy 50 Adenomas 50 Nanosensors 50 Stomach Cancer 50 Slow Progression 50 Microarray Analysis 50 Advanced Renal Cell 50 Companion Diagnostic 50 Cognitive Impairment 50 Breast Cancer Risk 50 risk stratification 50 Stem Cell Transplant 50 Hematological 50 Asthma Treatment 50 bioinformatic approaches 50 Asthma COPD 50 Novel Compounds 50 Neurogenesis 50 Levels Linked 50 Decision Biomarkers 50 Genes Predict 50 Molecular Biomarkers 50 Neoadjuvant Chemotherapy 50 Molecular Medicine Tri 50 Blood Stem Cells 50 Curaxin 50 Phase III AFFIRM 50 HDAC Inhibitor 50 Dementias 50 Breast Cancer Detection 50 Monoclonal 50 Novel Small Molecule 50 Nonalcoholic Steatohepatitis 50 Fatty Acids 50 Nerve Regeneration 50 Neurological Disease 50 MicroRNAs 50 Imaging Techniques 50 Potent Anti 50 Liver Disease 50 Randomized Clinical Trials 50 Renal Tumors 50 MEK Inhibitor 50 gefitinib Iressa 50 Collaborators Publish 50 microRNA expression 50 Reverse Cholesterol Transport 50 Overactive Bladder 50 Heart Failure Patients 50 Ultrasensitive 50 neutrophil gelatinase associated lipocalin 50 Nymox NX 50 pharmacodynamic parameters 50 Integrin 50 Sangamo BioSciences Announces 50 biomarker validation 50 Abstract Accepted 50 Antigens 50 Minimally Invasive Treatment 50 Cell Differentiation 50 SABCS 50 Relapsing Multiple Sclerosis 50 Preclinical Efficacy 50 molecular biomarker 50 Predict Risk 50 Genetic Susceptibility 50 Nutrigenomics 50 Stakeholder Opinions 50 Anticancer Agent 50 Nerve Cell 50 Stem Cell Therapies 50 Sentinel Lymph Node Biopsy 50 Contrast Agent 50 Genomic 50 multi analyte 50 Cholesterol Levels 50 Cerebral Cortex 50 Localized Prostate Cancer 50 Stem Cell Treatment 50 Cell Proliferation 50 Treatment Shows Promise 50 metabonomics 50 Squalamine 50 Cholesterol Drugs 50 Brain Cells 50 Vitro Diagnostics 50 sarcosine 50 exome sequencing 50 Induced Pluripotent Stem Cells 50 genetic determinants 50 Zinc Finger Nuclease 50 TLR9 agonists 50 Ribosome 50 Neuroinflammation 50 Dose Escalation 50 Disease Modifying 50 Sapacitabine 50 Proteome Research 50 Septic Shock 50 myeloproliferative disorders 50 Ocular Disease 50 Prostate Biopsy 50 Atopic Dermatitis 50 Cerebrospinal Fluid 50 Subgroup Analysis 50 Biochemical 50 biologic pathways 50 Metabolic Profiling 50 ptau 50 immunotherapeutic approaches 50 Lancet Neurology 50 Malignancy 50 Endometrial Cancer 50 gene fusions 50 Physiological Genomics 50 Aurora Kinase 50 Immunoassay 50 Chicago Multidisciplinary Symposium 50 Bazedoxifene 50 Osteoarthritis Patients 50 Quantum Dots 49 Catheterization 49 Reduced Risk 49 NuroPro ® 49 Prospective Randomized 49 Help Detect 49 Pivotal Clinical Trial 49 Biobanks 49 journal Arteriosclerosis Thrombosis 49 Kidney Transplant Patients 49 Transcriptional 49 Trodusquemine MSI 49 Blood Flow 49 Colorectal Cancers 49 Molecular Mechanism 49 Completes Patient Enrollment 49 Cytotoxic 49 immunochemical 49 Tumor Cell 49 VeriStrat 49 Gastrointestinal Disorders 49 Combo Therapy 49 Transdermal Patch 49 Magnetic Nanoparticles 49 journal Nature Chemistry 49 Neuroprotective Effects 49 Metabolic Disorders 49 Phase III Trials 49 Blood Clotting 49 Breast Cancer Symposium 49 Cardiometabolic 49 Patients Receiving 49 bioinformatics 49 Polyneuropathy 49 Cardiovascular Events 49 ECTRIMS 49 Randomized Double blind 49 Polymorphism 49 Whole Genome 49 BIOCOM Investor Conference 49 Endocrine Practice 49 Low Dose 49 Respiratory Virus 49 Gastrointestinal Cancer 49 Osteoporosis Drugs 49 NPM1 49 Phase 2b Clinical Trial 49 Aggressive Reduction 49 Hormone Therapies 49 Transcription Factor 49 Hereditary Breast 49 Computational Chemistry 49 prognostic marker 49 Glucocorticoid 49 Neoplasms 49 antiangiogenic agents 49 Microarray 49 Galectin 3 49 Protein Structures 49 Tumor Response 49 Translational Medicine 49 diagnostic assays 49 Elagolix 49 Darapladib 49 Proteases 49 Disease Progression 49 Chronic Myeloid Leukemia 49 immunoregulation 49 Pulmonary Hypertension 49 Alcohol Dependence 49 Neurotoxicity 49 Clinical Antipsychotic Trials 49 predictive biomarker 49 Lung Cancer Treatment 49 Statin Therapy 49 pharmacogenetic testing 49 Tyrosine Kinase Inhibitors 49 Skin Lesions 49 ASCO Annual Meeting 49 Synthetic Chemistry 49 Treatment Resistant 49 P#X# 49 Diabetes Complications 49 Fungal Infections 49 Mutational 49 optical biosensors 49 skin sterol 49 Therapy Evaluation 49 MD Ph.D. 49 ZFP Therapeutic 49 Coronary Arteries 49 Combination Therapy 49 Phenotypic 49 Brain Function 49 Shows Promising 49 Breast Cancer Patients 49 Liver Cancer 49 Referenced EEG 49 Neurobiological 49 Chemokine Receptor 49 Heart Transplant Recipients 49 HCV Protease Inhibitor 49 Neurome 49 Dehydrogenase 49 Gamma secretase 49 journal Nature Chemical Biology 49 Multiple Myeloma Patients 49 Confocal Microscopy 49 EGIR 49 Brain Atrophy 49 iTRAQ 49 Cervical Dysplasia 49 Premature Aging 49 Sequence Capture 49 Poster Session 49 molecular imaging radiopharmaceutical 49 Stem Cell Transplants 49 Bacterial Infections 49 Announces Poster Presentations 49 NASDAQ IDRA 49 metabolite identification 49 Meets Primary Endpoint 49 Cannabinoid 49 Brain Behavior 49 Biomacromolecules 49 Brain Plasticity 49 Drug Repositioning 49 Radiation Induced 49 Lung Cancers 49 Inhaled Corticosteroids 49 Musculoskeletal Disorders 49 Nature Structural 49 Diabetologia 49 druggable targets 49 Transplant Rejection 49 DNA methylation biomarker 49 pharmacogenetic 49 Anticancer Drug 49 Immunomedics Announces 49 Inflammatory Bowel Disease 49 Carfilzomib 49 Colorectal Adenomas 49 See CLINICAL PHARMACOLOGY 49 Vaccine Protects Against 49 Anticancer Agents 49 Acute Ischemic Stroke 49 delafloxacin 49 JAK2 Inhibitor 49 Colorectal Cancer Screening 49 journal Genes 49 Hormonal Therapy 49 Single Molecule 49 journal PLoS Genetics 49 Diabetic Foot Ulcer 49 Lipid Research 49 Nonalcoholic Fatty Liver Disease 49 HER1 49 II Clinical Trial 49 Peptide 49 Structure Function 49 Photochemistry 49 Findings Suggest 49 Adjuvant Therapy 49 Personalized Immunotherapy 49 Oral Microbiology 49 mtm laboratories 49 validating biomarkers 49 epigenetic therapies 49 NovaBay Aganocide compounds 49 #:#-# [023] 49 Brain Metastases 49 Cardiovascular Risk 49 Drug Delivery 49 Phase 2b Trial 49 Pharma Biotech 49 protein electrophoresis 49 genomic 49 Nucleic Acids Research 49 Predict Breast Cancer 49 Improved Survival 49 Apoptosis 49 ABRF 49 Telomere 49 ERYtech 49 PLoS Computational Biology 49 Progenitor Cell 49 Novel Inhibitor 49 Glycosylation 49 Protein Microarrays 49 Insulin Delivery 49 ALPCO 49 Molecular Psychiatry 49 Proteasome 49 gastrointestinal GI cancers 49 Skin Cancers 49 Preterm Birth 49 Chronic Myelogenous Leukemia 49 Metabolic Disorder 49 Valve Replacement 49 Advanced Functional Materials 49 Regimens 49 Circadian Clock 49 Male Infertility 49 Therapeutics Roundtable 49 Lung Cancer Risk 49 Prostate Cancer Survival 49 multiplex assay 49 Pharmacogenetics 49 Anticancer 49 Diabetic Patients 49 Endothelial Function 49 Li Fraumeni 49 Lp PLA 2 49 Biosimilars 49 Neurodegeneration 49 Demonstrates Sustained 49 Therapeutic Proteins 49 Clusterin 49 metabolic profiling 49 journal Oncogene 49 Outcome Sciences 49 Immune Responses 49 FDA Okays 49 Situ Hybridization 49 Diabetes Obesity 49 Romidepsin 49 Oral Cavity 49 G Protein Coupled 49 Etiology 49 MassGeneral Institute 49 Nucleic Acids 49 Genome Wide 49 Drug Combo 49 MSMB 49 HG PIN 49 nanomedicine 49 MALDI MS 48 proteomic biomarkers 48 Reproductive Toxicology 48 genomics transcriptomics 48 Tumor Targeted 48 Pancreatic 48 Investigational Agent 48 Immunosuppressive 48 Newly Diagnosed 48 Nature Reviews 48 Could Detect 48 magnetic resonance spectroscopy MRS 48 pralatrexate injection folate analogue 48 PDE# 48 Analytical Biochemistry 48 Molecular Evolution 48 Septin 9 48 LibiGel ® 48 sphingolipids 48 RNA Interference RNAi 48 pharmacological approaches 48 Thomas Ichim 48 Presents Preclinical Data 48 journal Cloning 48 HistoRx 48 diseases fat malabsorption 48 Less Invasive 48 Nuclear Receptor 48 Tissue Engineering 48 epigenetic mechanisms 48 Biocept 48 Patrice Milos 48 Antitumor Activity 48 resolvins 48 JAK Inhibitor 48 Hormone Receptor 48 molecular pathogenesis 48 Glycemia 48 Systems Biology 48 Vaccine Candidate 48 soluble CD# ligand 48 #F FDG PET 48 Nerve Cells 48 causative genes 48 Genetic variations 48 Affymetrix GeneChip ® 48 Implantable Device 48 Acute Myocardial Infarction 48 oligonucleotide therapeutics 48 Chiral Technology 48 TLR antagonists 48 Disease Diagnosis 48 Trastuzumab DM1 48 Gum Disease 48 neuropsychiatric diseases 48 HIF PH inhibitors 48 Rheumatoid Arthritis 48 Randomized Phase III 48 PhD DSc 48 Vulnerable Plaque 48 Neurodegenerative Disorders 48 Monocytes 48 journal Cell Metabolism 48 Pathogen Detection 48 Sangamo BioSciences 48 Pharmacotherapy 48 Observational Studies 48 Hematological Cancers 48 Previously Treated 48 ALK inhibitors 48 NASDAQ HLCS